FLNA

Filamin-A · P21333 · FLNA on Sugi Atlas →

0 patent compounds predicted against FLNA, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to FLNA by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy PHASE3COMPLETED
Treatment of Ectopic Calcification in Fahr's Disease or Syndrome PHASE2RECRUITING
The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis PHASE1RECRUITING
Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia PHASE1COMPLETED
Atopic Dermatitis in Atopy Predisposed Infants nanCOMPLETED
18F-FDG PET/TC in TIR3A e TIR3B nanENROLLING_BY_INVITATION
Molecular Analysis of Patients With Neuromuscular Disease nanRECRUITING
Genetic Analysis of Fraser Syndrome and Fryns Syndrome nanCOMPLETED
Application of Linkage Analysis in the Identification of Novel Hereditary Factors in Familial Aneurysms nanACTIVE_NOT_RECRUITING
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Corrective Exercise and Rehabilitation in Fanconi Anemia: A Case Study nanCOMPLETED
CTHRC1: A Biomarker for Evaluation of Rheumatoid Arthritis Disease Activity nanUNKNOWN
Natural History of Autosomal Dominant Hearing Loss nanRECRUITING
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease nanCOMPLETED
Genetic Markers for Focal Segmental Glomerulosclerosis nanCOMPLETED
Genetics of Fibromyalgia nanUNKNOWN
Nerve Ultrasound in Acquired and Genetic Sensory Neuronopathies nanNOT_YET_RECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
FA Clinical Outcome Measures nanACTIVE_NOT_RECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Frequency of SOD1 and C9orf72 Gene Mutations in French ALS nanCOMPLETED
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure nanRECRUITING
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa nanUNKNOWN
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) nanUNKNOWN
Familial Intracranial Aneurysm Study II nanCOMPLETED
Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon nanCOMPLETED
Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches nanRECRUITING
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a FLNA binder may also engage these)

ProteinNameSimilarity
Q8BTM8 1.000 Q8BTM8 →
Q8VHX6 1.000 Q8VHX6 →
Q14315 0.999 Q14315 →
Q80X90 0.997 Q80X90 →
D3ZHA0 0.996 D3ZHA0 →
FLNB Filamin-B 0.995 landscape →
Q9VEN1 0.989 Q9VEN1 →
P13466 0.979 P13466 →
Q61233 0.974 Q61233 →
LCP1 Plastin-2 0.972 landscape →
Q6P698 0.972 Q6P698 →
Q99K51 0.972 Q99K51 →
Q32PH8 0.971 Q32PH8 →
P62631 0.971 P62631 →
P31669 0.971 P31669 →
O08688 0.971 O08688 →
Q63598 0.971 Q63598 →
Q92178 0.971 Q92178 →
P16638 0.970 P16638 →
P16081 0.970 P16081 →
P00789 0.970 P00789 →
P50256 0.970 P50256 →
Q9ZNT0 0.970 Q9ZNT0 →
Q5RAZ4 0.970 Q5RAZ4 →
Q941L3 0.970 Q941L3 →
A7E3Q8 0.970 A7E3Q8 →
A0A286R227 0.970 A0A286R227 →
Q07009 0.970 Q07009 →
Q8K009 0.970 Q8K009 →
O94489 0.970 O94489 →